|Day Low/High||109.61 / 111.99|
|52 Wk Low/High||83.73 / 114.26|
European stocks tested multi-month highs Wednesday after better-than-expected business sentiment data from Germany and an upgrade to the fourth quarter pace of growth in the United Kingdom.
Bayer shares fell after the drugmaker posted solid full-year earnings but said its crop sciences unit would see modest growth in 2017 as it completes its $66 billion Monsanto takeover.
The details matter in this case.
Billionaire investors appear to see good times ahead with a fellow billionaire in the White House.
David Einhorn's hedge fund, Greenlight Capital, disclosed fresh positions in four stocks.
With nearly $800 million invested in the stock, Apple remains David Einhorn's top investment, but a he's buying up notable positions in some other companies, too.
Einhorn picked up new positions in Syngenta and others.
Chemical companies, lumber producers and other sectors that should benefit from capital spending look to do well going forward.
I prefer the one-way biased, at-the-money long call shooter trade expiring in March.
Losing a job is always tough, but these pink slips were particularly explosive.
Monsanto Company (NYSE: MON) announced that its Board of Directors, at a regularly scheduled meeting held today, declared a quarterly dividend on its common stock of 54 cents per share.
After a decent year, Trump looms large over M&A activity, cross-border deals especially. The Deal, TheStreet's sister publication for dealmakers is out with its 2016 ranking of advisers.
M&A co-head Alan Klein advises ChemChina, Microsoft, ADT and Tyco and sneaks in a few movies on the side.
Ag company FMC is now poised for breakout growth because it invested in itself and made smart acquisitions, Jim Cramer says.
Jim Cramer explains how bullish comments from one semiconductor equipment maker lifts shares throughout the sector.
Shares of the target rose after president-elect's team touted companies' offer to spend billions in R&D
Monsanto Company (NYSE: MON) and NRGene announced today that the companies have reached a non-exclusive, multi-year global licensing agreement on NRGene's genome-analysis technology to enhance Monsanto's ability to predict,...
Elizabeth Lim, Mergermarket America head research editor, expects further energy consolidation and increased media mergers in 2017.
The stock's big price increase after better-than-expected earnings will lead to a retracement and very soon.
The Climate Corporation, a subsidiary of Monsanto Company (NYSE: MON), today unveiled for the first time more than 35 projects in its research and development pipeline.
Monsanto Company (NYSE: MON) announced 2017 updates on progress made across its research and development (R&D) pipeline over the past year.
In the first quarter, Monsanto Company (NYSE: MON) delivered higher earnings per share (EPS) than the prior year thanks to the strength of the company's South American business.
On Thursday investors are keeping a close eye on labor market data.
Monsanto Company (NYSE: MON) announced today that it has reached a new global licensing agreement with the Broad Institute of MIT and Harvard for the use of the novel CRISPR-Cpf1 genome-editing technology in agriculture.
Jim Cramer calls Monsanto a takeover target and says AGCO is the buyer.
Monsanto Company (NYSE: MON) announced it will issue the company's financial results for its fiscal 2017 first quarter and annual research and development pipeline update on Thursday, Jan.